Chicago Equity Partners’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
GGHC
NAMA
AIM
Chicago Equity Partners's VCYT Position: Q1 2020 in Review
Chicago Equity Partners sold out of Veracyte (VCYT) in Q1 2020, closing a stake of 22,890 shares — an estimated $639K sold.
Chicago Equity Partners first reported a position in VCYT in Q2 2019 and held it in 3 quarters. The position peaked at $1.07M in Q3 2019. 165 funds tracked by Wall St. Rank hold VCYT as of Q1 2020.
- Chicago Equity Partners reported no remaining Veracyte position as of Q1 2020 after selling out during the quarter.
- Chicago Equity Partners sold 22,890 Veracyte shares in Q1 2020, an estimated $639K.
- Chicago Equity Partners first reported a position in Veracyte in Q2 2019 and held it in 3 quarters.
- Chicago Equity Partners's Veracyte position peaked at $1.07M in Q3 2019.
- 165 funds tracked by Wall St. Rank held Veracyte as of Q1 2020.
Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.